NM_005629.4:c.1452C>G

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_005629.4(SLC6A8):​c.1452C>G​(p.Leu484Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000132 in 1,208,822 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 50 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L484L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000081 ( 0 hom., 2 hem., cov: 23)
Exomes 𝑓: 0.00014 ( 0 hom. 48 hem. )

Consequence

SLC6A8
NM_005629.4 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.574

Publications

1 publications found
Variant links:
Genes affected
SLC6A8 (HGNC:11055): (solute carrier family 6 member 8) The protein encoded by this gene is a plasma membrane protein whose function is to transport creatine into and out of cells. Defects in this gene can result in X-linked creatine deficiency syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
SLC6A8 Gene-Disease associations (from GenCC):
  • creatine transporter deficiency
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.161).
BP6
Variant X-153694403-C-G is Benign according to our data. Variant chrX-153694403-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 382728.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.574 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 2 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC6A8NM_005629.4 linkc.1452C>G p.Leu484Leu synonymous_variant Exon 10 of 13 ENST00000253122.10 NP_005620.1 P48029-1X5D9C4
SLC6A8NM_001142805.2 linkc.1422C>G p.Leu474Leu synonymous_variant Exon 10 of 13 NP_001136277.1 P48029Q59EV7
SLC6A8NM_001142806.1 linkc.1107C>G p.Leu369Leu synonymous_variant Exon 10 of 13 NP_001136278.1 P48029-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC6A8ENST00000253122.10 linkc.1452C>G p.Leu484Leu synonymous_variant Exon 10 of 13 1 NM_005629.4 ENSP00000253122.5 P48029-1

Frequencies

GnomAD3 genomes
AF:
0.0000807
AC:
9
AN:
111551
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000943
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000151
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000273
AC:
5
AN:
182849
AF XY:
0.0000295
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000614
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000137
AC:
150
AN:
1097271
Hom.:
0
Cov.:
34
AF XY:
0.000132
AC XY:
48
AN XY:
362753
show subpopulations
African (AFR)
AF:
0.0000379
AC:
1
AN:
26386
American (AMR)
AF:
0.00
AC:
0
AN:
35198
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19379
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30205
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54122
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40495
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4127
European-Non Finnish (NFE)
AF:
0.000172
AC:
145
AN:
841297
Other (OTH)
AF:
0.0000868
AC:
4
AN:
46062
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000807
AC:
9
AN:
111551
Hom.:
0
Cov.:
23
AF XY:
0.0000593
AC XY:
2
AN XY:
33727
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30622
American (AMR)
AF:
0.0000943
AC:
1
AN:
10607
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2642
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3531
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2676
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6053
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
238
European-Non Finnish (NFE)
AF:
0.000151
AC:
8
AN:
52995
Other (OTH)
AF:
0.00
AC:
0
AN:
1503
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000945
EpiCase
AF:
0.000164
EpiControl
AF:
0.00

ClinVar

Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 08, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SLC6A8: BP4, BP7 -

Creatine transporter deficiency Benign:1
Nov 13, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Aug 18, 2019
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.55
CADD
Benign
3.5
DANN
Benign
0.65
PhyloP100
-0.57
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs376421364; hg19: chrX-152959858; API